HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 72/1/157    most recent biolreprod.104.033308v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal My Folders Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ghanayem, B.I. Articles by Bishop, J.B. Search for Related Content PubMed PubMed Citation Articles by Ghanayem, B.I. Articles by Bishop, J.B. Agricola Articles by Ghanayem, B.I. Articles by Bishop, J.B.

Comparison of Germ Cell Mutagenicity in Male CYP2E1-Null and Wild-Type Mice Treated with Acrylamide: Evidence Supporting a Glycidamide-Mediated Effect

Laboratory of Pharmacology and Chemistry,² Toxicology Operations Branch,³ Biostatistics Branch,⁴ Office of Program Development,⁵ National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709

Acrylamide is an animal carcinogen and probable human carcinogen present in appreciable amounts in heated carbohydrate-rich foodstuffs. It is also a germ cell mutagen, inducing dominant lethal mutations and heritable chromosomal translocations in postmeiotic sperm of treated mice. Acrylamide's affinity for male germ cells has sometimes been overlooked in assessing its toxicity and defining human health risks. Previous investigations of acrylamide's germ cell activity in mice showed stronger effects after repeated administration of low doses compared with a single high dose, suggesting the possible involvement of a stable metabolite. A key oxidative metabolite of acrylamide is the epoxide glycidamide, generated by cytochrome P4502E1 (CYP2E1). To explore the role of CYP2E1 metabolism in the germ cell mutagenicity of acrylamide, CYP2E1-null and wild-type male mice were treated by intraperitoneal injection with 0, 12.5, 25, or 50 mg acrylamide (5 ml saline)^–1 kg^–1 day^–1 for 5 consecutive days. At defined times after exposure, males were mated to untreated B6C3F₁ females. Females were killed in late gestation and uterine contents were examined. Dose-related increases in resorption moles (chromosomally aberrant embryos) and decreases in the numbers of pregnant females and the proportion of living fetuses were seen in females mated to acrylamide-treated wild-type mice. No changes in any fertility parameters were seen in females mated to acrylamide-treated CYP2E1-null mice. Our results constitute the first unequivocal demonstration that acrylamide-induced germ cell mutations in male mice require CYP2E1-mediated epoxidation of acrylamide. Thus, CYP2E1 polymorphisms in human populations, resulting in variable enzyme metabolic activities, may produce differential susceptibilities to acrylamide toxicities.

¹ Correspondence: Burhan I. Ghanayem, National Institute of Environmental Health Sciences, P.O. Box 12233, MD B3-10, 111 Alexander Dr., Research Triangle Park, NC 27709. FAX: 919 541 4632; ghanayem{at}niehs.nih.gov

This article has been cited by other articles:

				B. I. Ghanayem, R. Bai, and L. T. Burka Effect of Dose Volume on the Toxicokinetics of Acrylamide and Its Metabolites and 2-Deoxy-D-glucose Drug Metab. Dispos., February 1, 2009; 37(2): 259 - 263. [Abstract] [Full Text] [PDF]

				A. Besaratinia and G. P. Pfeifer A review of mechanisms of acrylamide carcinogenicity Carcinogenesis, March 1, 2007; 28(3): 519 - 528. [Abstract] [Full Text] [PDF]

				T. R. Fennell, S. C. J. Sumner, R. W. Snyder, J. Burgess, and M. A. Friedman Kinetics of Elimination of Urinary Metabolites of Acrylamide in Humans Toxicol. Sci., October 1, 2006; 93(2): 256 - 267. [Abstract] [Full Text] [PDF]

				B. I. Ghanayem, L. P. McDaniel, M. I. Churchwell, N. C. Twaddle, R. Snyder, T. R. Fennell, and D. R. Doerge Role of CYP2E1 in the Epoxidation of Acrylamide to Glycidamide and Formation of DNA and Hemoglobin Adducts Toxicol. Sci., December 1, 2005; 88(2): 311 - 318. [Abstract] [Full Text] [PDF]